4D Molecular Therapeutics Balance Sheet (2019-2026) | FDMT

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
90.99M153.00M75.97M113.48M108.30M52.35M78.57M236.31M275.68M249.11M275.59M189.06M187.54M149.34M133.53M77.16M48.55M60.24M72.49M70.37M
Short-term Investments (Quarter)
70.69M94.78M160.18M127.60M119.42M161.20M121.89M74.03M43.99M39.12M250.32M352.88M314.35M275.54M187.91M216.07M256.51M342.41M318.40M290.96M
Cash & Current Investments (Quarter)
161.68M247.78M236.15M241.09M227.72M213.55M200.45M310.34M319.66M288.23M525.91M541.95M501.89M424.88M321.44M293.23M305.06M402.65M390.89M361.33M
Receivables - Net (Quarter)
0.80M0.05M
Receivables - Other (Quarter)
0.70M0.70M
Receivables (Quarter)
0.80M0.75M0.70M
Prepaid Assets (Quarter)
3.27M8.46M6.89M5.43M4.76M6.96M6.59M7.43M8.58M8.36M9.68M10.69M8.87M10.05M11.13M10.06M7.31M10.48M14.47M17.01M
Current Assets (Quarter)
165.73M256.28M243.05M246.52M232.48M220.51M207.04M317.78M328.24M296.59M535.59M552.63M510.76M434.93M332.57M303.29M312.38M413.13M405.36M382.96M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
8.79M14.39M18.46M21.10M22.05M22.26M21.61M21.30M20.74M20.13M19.46M18.76M19.87M19.53M18.75M17.50M16.15M14.87M13.59M12.38M
Long-Term Investments (Quarter)
65.49M67.65M48.36M20.53M11.12M4.91M1.41M10.95M62.94M35.72M48.78M80.58M137.00M123.81M67.17M111.38M66.74M69.30M
Other Non-Current Assets (Quarter)
0.60M0.60M0.88M0.96M1.05M1.08M1.26M1.08M0.68M0.68M0.77M2.32M2.86M4.26M7.04M9.39M9.38M9.19M9.86M11.44M
Non-Current Assets (Quarter)
74.89M97.21M81.88M56.41M47.69M41.34M36.98M34.73M33.37M43.30M94.30M67.48M93.27M125.45M183.16M170.35M111.61M153.58M107.54M109.66M
Assets (Quarter)
240.62M353.49M324.93M302.94M280.16M261.85M244.02M352.50M361.61M339.89M629.88M620.12M604.03M560.38M515.73M473.64M423.98M566.71M512.90M492.62M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
3.71M4.76M2.68M3.32M1.48M3.32M2.41M3.49M4.71M3.52M4.22M3.43M2.92M4.39M4.15M8.70M6.86M11.16M14.69M12.52M
Payables (Quarter)
3.71M4.76M2.68M3.32M1.48M3.32M2.41M3.49M4.71M3.52M4.22M3.43M2.92M4.39M4.15M8.70M6.86M11.16M14.69M12.52M
Accumulated Expenses (Quarter)
3.68M3.99M5.26M2.93M7.24M5.69M5.41M3.96M10.19M8.15M4.52M5.49M9.61M18.87M5.66M19.19M24.19M13.81M6.24M25.43M
Other Accumulated Expenses (Quarter)
0.42M1.77M0.21M0.75M0.19M0.38M0.04M0.05M0.16M0.10M0.14M0.10M0.12M0.11M0.16M0.10M0.11M0.13M0.20M0.12M
Current Leases (Quarter)
1.23M2.04M2.60M2.63M2.65M2.68M3.10M3.13M3.15M3.17M3.20M5.09M5.64M5.68M5.72M5.70M5.59M5.49M5.37M
Current Deferred Revenue (Quarter)
4.74M5.09M3.87M2.26M2.21M1.96M0.78M1.42M1.23M0.27M1.32M1.32M1.31M0.26M0.87M1.07M0.36M0.36M0.36M0.36M
Total Current Liabilities (Quarter)
11.37M16.34M12.09M14.33M13.56M15.73M11.28M13.75M18.16M18.95M16.40M19.40M29.46M29.15M26.90M34.68M37.11M43.98M43.40M47.67M
Non-Current Liabilities
Non-Current Debt (Quarter)
19.59M
Non-Current Deffered Revenue (Quarter)
2.96M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
14.26M
Other Non-Current Liabilities (Quarter)
0.38M
Total Non-Current Liabilities (Quarter)
84.57M
Total Liabilities (Quarter)
84.96M
Shareholder's Equity
Common Equity (Quarter)
407.66M
Total Debt (Quarter)
19.59M
Liabilities and Shareholders Equity (Quarter)
492.62M
Retained Earnings (Quarter)
-858.00M
Treasury Shares (Quarter)
1.82M